• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三结构域蛋白 25 通过调节 PTEN/AKT 通路与肝癌细胞的表阿霉素耐药相关。

Tripartite motif protein 25 is associated with epirubicin resistance in hepatocellular carcinoma cells via regulating PTEN/AKT pathway.

机构信息

Department of Interventional Therapy, The People's Hospital of Jianhu, Jianhu, 224700, Jiangsu, P. R. China.

Department of Intensive Medicine, The People's Hospital of Jianhu, Jianhu, 224700, Jiangsu, P. R. China.

出版信息

Cell Biol Int. 2020 Jul;44(7):1503-1513. doi: 10.1002/cbin.11346. Epub 2020 Apr 28.

DOI:10.1002/cbin.11346
PMID:32196840
Abstract

Tripartite motif protein 25 (TRIM25) expression was altered in various human cancers. Herein, we found that the expression of TRIM25 was elevated in hepatocellular carcinoma (HCC) tissues and cell lines. Knockdown of TRIM25 increased the sensitivity of HCC HepG2 cells to epirubicin (EPI), as indicated by reduced cell viability, enhanced cell apoptosis, and downregulated P-glycoprotein (P-gp) and multiple drug-resistance protein 1 (MRP1). Moreover, TRIM25 knockdown strengthened the effects of EPI on phosphatase and tensin homolog (PTEN) and phosphorylated (p)-AKT. However, overexpression of TRIM25 exerted an opposite effect, weakening the sensitivity of Huh7 to EPI, and obviously increasing PTEN and reducing p-AKT. Most important, all the changes induced by TRIM25 overexpression in Huh7 were reversed with additional treatment of LY294002 (an AKT pathway inhibitor). Notably, coimmunoprecipitation experiments confirmed the interaction between TRIM25 and PTEN. Knockdown of TRIM25 resulted in reduced ubiquitination of PTEN protein. Collectively, our data suggested that TRIM25 enhanced EPI resistance via modulating PTEN/AKT pathway, and targeting TRIM25 may enhance the sensitivity of HCC cells toward chemotherapy drugs.

摘要

三结构域蛋白 25(TRIM25)在各种人类癌症中的表达发生改变。在此,我们发现 TRIM25 在肝癌(HCC)组织和细胞系中的表达上调。TRIM25 的敲低增加了 HCC HepG2 细胞对表柔比星(EPI)的敏感性,表现为细胞活力降低、细胞凋亡增强以及 P-糖蛋白(P-gp)和多药耐药蛋白 1(MRP1)下调。此外,TRIM25 的敲低增强了 EPI 对磷酸酶和张力蛋白同源物(PTEN)和磷酸化(p)-AKT 的作用。然而,TRIM25 的过表达则产生相反的效果,减弱 Huh7 对 EPI 的敏感性,明显增加 PTEN 并减少 p-AKT。最重要的是,Huh7 中 TRIM25 过表达引起的所有变化都随着 AKT 通路抑制剂 LY294002 的额外处理而逆转。值得注意的是,免疫共沉淀实验证实了 TRIM25 与 PTEN 之间的相互作用。TRIM25 的敲低导致 PTEN 蛋白的泛素化减少。总之,我们的数据表明,TRIM25 通过调节 PTEN/AKT 通路增强了 EPI 耐药性,靶向 TRIM25 可能增强 HCC 细胞对化疗药物的敏感性。

相似文献

1
Tripartite motif protein 25 is associated with epirubicin resistance in hepatocellular carcinoma cells via regulating PTEN/AKT pathway.三结构域蛋白 25 通过调节 PTEN/AKT 通路与肝癌细胞的表阿霉素耐药相关。
Cell Biol Int. 2020 Jul;44(7):1503-1513. doi: 10.1002/cbin.11346. Epub 2020 Apr 28.
2
The deubiquitinase USP10 restores PTEN activity and inhibits non-small cell lung cancer cell proliferation.去泛素化酶 USP10 可恢复 PTEN 的活性并抑制非小细胞肺癌细胞的增殖。
J Biol Chem. 2021 Sep;297(3):101088. doi: 10.1016/j.jbc.2021.101088. Epub 2021 Aug 18.
3
The ubiquitin ligase TRIM25 inhibits hepatocellular carcinoma progression by targeting metastasis associated 1 protein.泛素连接酶 TRIM25 通过靶向转移相关蛋白 1 抑制肝癌进展。
IUBMB Life. 2017 Oct;69(10):795-801. doi: 10.1002/iub.1661. Epub 2017 Aug 31.
4
Low‑intensity ultrasound enhances the antitumor effects of doxorubicin on hepatocellular carcinoma cells through the ROS‑miR‑21‑PTEN axis.低强度超声通过 ROS- miR-21-PTEN 轴增强阿霉素对肝癌细胞的抗肿瘤作用。
Mol Med Rep. 2020 Mar;21(3):989-998. doi: 10.3892/mmr.2020.10936. Epub 2020 Jan 13.
5
MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.微小RNA-21通过PTEN/蛋白激酶B信号通路抑制自噬,从而介导肝癌细胞对索拉非尼的耐药性。
Oncotarget. 2015 Oct 6;6(30):28867-81. doi: 10.18632/oncotarget.4814.
6
microRNA-19a-3p promotes tumor metastasis and chemoresistance through the PTEN/Akt pathway in hepatocellular carcinoma.microRNA-19a-3p 通过 PTEN/Akt 通路促进肝癌的肿瘤转移和化疗耐药性。
Biomed Pharmacother. 2018 Sep;105:1147-1154. doi: 10.1016/j.biopha.2018.06.097. Epub 2018 Jun 21.
7
Synergistic anticancer activity of 20(S)-Ginsenoside Rg3 and Sorafenib in hepatocellular carcinoma by modulating PTEN/Akt signaling pathway.20(S)-人参皂苷 Rg3 与索拉非尼通过调控 PTEN/Akt 信号通路协同抑制肝癌。
Biomed Pharmacother. 2018 Jan;97:1282-1288. doi: 10.1016/j.biopha.2017.11.006. Epub 2017 Dec 14.
8
Long Noncoding RNA lncARSR Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Modulating PTEN-PI3K/Akt Pathway.长非编码 RNA lncARSR 通过调控 PTEN-PI3K/Akt 通路促进肝癌多柔比星耐药。
J Cell Biochem. 2017 Dec;118(12):4498-4507. doi: 10.1002/jcb.26107. Epub 2017 Jun 9.
9
TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway.TRIM25 通过靶向 Keap1-Nrf2 通路促进肝癌细胞的存活和生长。
Nat Commun. 2020 Jan 17;11(1):348. doi: 10.1038/s41467-019-14190-2.
10
TRIM25 is associated with cisplatin resistance in non-small-cell lung carcinoma A549 cell line via downregulation of 14-3-3σ.TRIM25通过下调14-3-3σ与非小细胞肺癌A549细胞系中的顺铂耐药相关。
Biochem Biophys Res Commun. 2017 Nov 4;493(1):568-572. doi: 10.1016/j.bbrc.2017.08.151. Epub 2017 Sep 1.

引用本文的文献

1
A Perspective on Therapeutic Targeting Against Ubiquitin Ligases to Stabilize Tumor Suppressor Proteins.靶向泛素连接酶以稳定肿瘤抑制蛋白的治疗前景
Cancers (Basel). 2025 Feb 13;17(4):626. doi: 10.3390/cancers17040626.
2
TRIM25: A Global Player of Cell Death Pathways and Promising Target of Tumor-Sensitizing Therapies.TRIM25:细胞死亡途径的全球参与者及肿瘤增敏治疗的潜在靶点
Cells. 2025 Jan 7;14(2):65. doi: 10.3390/cells14020065.
3
TRIM25, TRIM28 and TRIM59 and Their Protein Partners in Cancer Signaling Crosstalk: Potential Novel Therapeutic Targets for Cancer.
TRIM25、TRIM28和TRIM59及其在癌症信号串扰中的蛋白质伙伴:癌症潜在的新型治疗靶点
Curr Issues Mol Biol. 2024 Sep 25;46(10):10745-10761. doi: 10.3390/cimb46100638.
4
Mechanism of multidrug resistance to chemotherapy mediated by P‑glycoprotein (Review).P-糖蛋白介导的多药耐药化疗机制(综述)。
Int J Oncol. 2023 Nov;63(5). doi: 10.3892/ijo.2023.5567. Epub 2023 Sep 1.
5
Intricate confrontation: Research progress and application potential of TRIM family proteins in tumor immune escape.错综复杂的对抗:TRIM 家族蛋白在肿瘤免疫逃逸中的研究进展与应用潜力。
J Adv Res. 2023 Dec;54:147-179. doi: 10.1016/j.jare.2023.01.011. Epub 2023 Feb 2.
6
Small Nucleolar RNA and C/D Box 15B Regulate the TRIM25/P53 Complex to Promote the Development of Endometrial Cancer.小核仁RNA与C/D盒15B调控TRIM25/P53复合物以促进子宫内膜癌的发展。
J Oncol. 2022 Sep 26;2022:7762708. doi: 10.1155/2022/7762708. eCollection 2022.
7
Combined Treatment of Tanshinone I and Epirubicin Revealed Enhanced Inhibition of Hepatocellular Carcinoma by Targeting PI3K/AKT/HIF-1α.丹参酮 I 与表阿霉素联合治疗通过靶向 PI3K/AKT/HIF-1α 增强对肝癌的抑制作用。
Drug Des Devel Ther. 2022 Sep 19;16:3197-3213. doi: 10.2147/DDDT.S360691. eCollection 2022.
8
TRIM proteins in hepatocellular carcinoma.TRIM 蛋白在肝细胞癌中的作用。
J Biomed Sci. 2022 Sep 13;29(1):69. doi: 10.1186/s12929-022-00854-7.
9
Tripartite motif-containing 25 facilitates immunosuppression and inhibits apoptosis of glioma via activating NF-κB.三结构域蛋白 25 通过激活 NF-κB 促进胶质瘤的免疫抑制和抑制细胞凋亡。
Exp Biol Med (Maywood). 2022 Sep;247(17):1529-1541. doi: 10.1177/15353702221099460. Epub 2022 Jun 20.
10
Comprehensive profiling of the TRIpartite motif family to identify pivot genes in hepatocellular carcinoma.全面分析三部分基序家族,鉴定肝癌中的枢纽基因。
Cancer Med. 2022 Apr;11(7):1712-1731. doi: 10.1002/cam4.4552. Epub 2022 Feb 9.